Axonyx Off Hook For Alzheimer's Drug Securities Suit
A federal appeals court has extinguished a securities class action alleging pharmaceutical firm Axonyx Inc. misled investors about the promise of its experimental Alzheimer's disease treatment Phenserine....To view the full article, register now.
Already a subscriber? Click here to view full article